Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sarcoma Alliance for Research Through Collaboration (SARC) Multicenter Trial: A Phase II Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

NCT00401388 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT00401388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00401388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sarcoma Alliance for Research Through Collaboration (SARC) Multicenter Trial: A Phase II Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
Lead sponsor
AEterna Zentaris
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2006
Completion date
October 31, 2011
Enrollment
72 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar soft part sarcomas, chondrosarcomas, extra skeletal myxoid chondrosarcomas